Sigma Healthcare Selloff Attracts New Bulls -- Market Talk

Dow Jones

2025/12/12

0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

December 11, 2025 19:20 ET (00:20 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2590754024"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590754024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590754024?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 08:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590754024","market":"fut","top_or_hot":-1,"title":"Sigma Healthcare Selloff Attracts New Bulls -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0020 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a> gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2025 19:20 ET (00:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sigma Healthcare Selloff Attracts New Bulls -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSigma Healthcare Selloff Attracts New Bulls -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-12 08:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0020 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a> gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2025 19:20 ET (00:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7103","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2590754024","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590754024","pubTimestamp":1765498800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7103":"保健护理产品经销商","BK4585":"ETF&股票定投概念","BK4588":"碎股","XLV":"健康照护类股ETF-SPDR","BK4581":"高盛持仓","BK4137":"综合支持服务","SIG.AU":"SIGMA HEALTHCARE LTD","HCSG":"Healthcare Svcs Group Inc","LABU":"三倍做多标普生物-Direxion","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XBI":"SPDR S&P Biotech ETF","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC"},"translate_title":"Sigma Healthcare抛售吸引了新的多头——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"XBI":0.6,"HCSG":1.5,"SIG.AU":0.9,"LABU":0.6},"content_text":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 19:20 ET (00:20 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}